Endo Pharmaceuticals (NASDAQ:ENDP) said today it has agreed to acquire pelvic health devices and therapies provider American Medical Systems (AMS) for $30 per share in cash, or a total of $2.9 billion including assumption of $312 million in debt.
The combined company will be positioned to deliver more comprehensive healthcare solutions in branded pharmaceuticals, generics and devices and services in key areas of urology and pain Endo said.
The combination, which would have generated $3 billion in revenues on a 2011 pro form basis, will provide cost-effective solutions across the entire urology spectrum, the companies said.
Endo noted that AMSí anticipated revenue and earnings growth, combined with strong margins and free cash flow generation, make the acquisition a compelling strategic fit.
Endo said the transaction will be immediately accretive to 2011 earnings on an adjusted basis, and is expected to close late in the third quarter.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.